In vivo and in vitro evaluation of essential oils from Ligusticum chuanxiong HORT on the transdermal delivery of flurbiprofen in rabbits

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 6, 2006, Pages 1217-1222

  Zhang, Li Chao ^a   Hu, Jin Hong ^a   Li, Ling ^b   Gao, Li Hong ^a   Zhu, Quan Gang ^a   Li, Zhen ^a   Wang, Zhong Zhuang ^a   Su, Ding Feng ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chuanxiong; Essential oil; Flurbiprofen; Phthalide; Skin permeation enhancement

Indexed keywords

1,3,5 UNDECATRIENE; 3 BUTYLPHTHALIDE; 4 CYMENE; ALPHA CEDRENE; ALPHA SELINENE; BUTYLIDENEPHTHALIDE; CARBOMER; ESSENTIAL OIL; FLURBIPROFEN; LIGUSTICUM CHUANXIONG EXTRACT; LIGUSTILIDE; LINOLEIC ACID ETHYL ESTER; NEOCNIDILIDE; OLEIC ACID; PLANT EXTRACT; SELINENE; SENKYUNOLIDE; SPATHULENOL; TERPINEN 4 OL; TERPINENE; TERPINOLENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG IDENTIFICATION; DRUG PENETRATION; GAS CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; LIGUSTICUM; MALE; MASS SPECTROMETRY; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; RABBIT; SKIN CONDUCTANCE; SKIN PERMEABILITY; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUGS, CHINESE HERBAL; FLURBIPROFEN; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; OILS, VOLATILE; POLYVINYLS; RABBITS; SKIN; SKIN ABSORPTION;

EID: 33744941070     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1217     Document Type: Article

References (23)

1. Finnin B. C., Mogran T. M., J. Pharm. Sci., 88, 955-958 (1999).
2. El-Kattan A. F., Asbill C. S., Michniak B. B., Int. J. Pharm., 198, 179-189 (2000).
3. Purdon C. H., Azzi C. G., Zhang J., Smith E. W., Maibach, H. I., Crit. Rev. Ther. Drug Carrier. Syst., 21, 97-132 (2004).
4. Huang Y. B., Fang J. Y., Hung C. H., Wu P. C., Tsai Y. H., Biol. Pharm. Bull., 22, 642-646 (1999).
5. Monti D., Chetoni P., Burgalassi S., Najarro M., Saettone M. F., Boldrini E., Int. J. Pharm., 237, 209-214 (2002).
6. Fang J. Y., Leu Y. L., Hwang T. L., Cheng H. C., Biol. Pharm. Bull., 27, 1819-1825 (2004).
7. Liang M. J., He L. C., Yang G. D., Life Sci., 78, 128-133 (2005).
8. Hong Z. Y., Wang X. Z., Le J., Zhang D. C., Chai Y. F., Liu Z. L., J. Chin. Pharm. Sci., 11, 31-34 (2002).
9. Namba T., Sekiya K., Kadota S., Hattori M., Katayama K., Koizumi T., Yakugaku Zasshi, 112, 638-644 (1992).
10. Auclair F., Besnard M., Dupont C., Wepierre J., Skin Pharmacol., 4, 1-8 (1991).
11. Zhu X. Z., Li X. Y., Liu J., Eur. J. Pharmacol., 500, 221-230 (2004).
12. Tian J. W., Fu F. H., Jiang W. L., Wang C. Y., Sun F., Zhang T. P., Zhongguo Zhong Yao Za Zhi, 30, 466-468 (2005).
13. Morimoto Y., Hayashi T., Kawabata S., Seki T., Sugibayashi K., Biol. Pharm. Bull., 23, 1254-1257 (2000).
14. Fang J. Y., Hwang T. L., Fang C. L., Chiu H. C., Int. J. Pharm., 255, 153-166 (2003).
15. Fang J. Y., Chiu H. C., Wu J. T., Chiang Y. R., Hsc S. H., Int. J. Pharm., 276, 163-173 (2004).
16. Fang J. Y., Hwang T. L., Leu Y. L., Int. J. Pharm., 250, 313-325 (2003).
17. Zhang X. Z., Xiao H. B., Xu Q., Li X. L., Wang J. N., Liang X. M., J. Chromatogr. Sci., 41, 428-433 (2003).
18. Li H. X., Ding M. Y., Yu J. Y., J. Chromatogr. Sci., 40, 156-161 (2002).
19. Chi S. C., Park E. S., Kim H., Int. J. Pharm., 126, 267-274 (1995).
20. Williams A. C., Barry B. W., Pharm. Res., 8, 17-24 (1991).
21. Krishnaiah Y. S., Satyanarayana V., Bhaskar P., Int. J. Pharm., 247, 91-102 (2002).
22. Godwin D. A., Michniak B. B., Drug Dev. Ind. Pharm., 25, 905-915 (1999).
23. Okabe H., Takayama K., Ogura A., Nagai T., Drug Des. Deliv., 4, 313-321 (1989).